Opus Genetics, Inc.

NasdaqCM:IRD Stock Report

Market Cap: US$139.3m

Opus Genetics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqCM:IRD Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
09 Dec 25SellUS$8,600,000Foundation Fighting Blindness, Endowment ArmCompany4,000,000US$2.15

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of IRD?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders10,063,41214.6%
General Public17,661,08125.6%
Institutions20,220,23029.3%
VC/PE Firms21,019,48530.5%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 118.5%.


Top Shareholders

Top 25 shareholders own 72.96% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
24.2%
Bios Equity Partners LP
16,694,485US$33.7m0%29.5%
7.96%
Foundation Fighting Blindness
5,492,171US$11.1m-42.1%no data
6.27%
Perceptive Advisors LLC
4,325,000US$8.7m0%0.18%
5.34%
Bios Capital Management, LP
3,683,429US$7.4m0%100.0%
4.85%
Nantahala Capital Management, LLC
3,345,923US$6.8m0%0.36%
4.72%
Leslie Kreis
3,252,764US$6.6m0%no data
4.72%
Aaron Glenn Fletcher
3,252,764US$6.6m0%no data
2.51%
Cameron Gallagher
1,730,926US$3.5m101%no data
1.95%
The Vanguard Group, Inc.
1,342,025US$2.7m35.3%no data
1.8%
Mink Brook Asset Management LLC
1,237,947US$2.5m3.37%1.62%
1.6%
Opaleye Management Inc.
1,100,000US$2.2m-9.84%0.27%
1.38%
Adage Capital Management, L.P.
954,996US$1.9m0%no data
1.1%
George Magrath
760,957US$1.5m10.1%no data
1.07%
Bleichroeder LP
736,842US$1.5m0%0.26%
0.82%
Voss Capital, LP
562,377US$1.1m3.92%0.06%
0.68%
Geode Capital Management, LLC
468,937US$947.3k31.8%no data
0.35%
Richard Rodgers
239,151US$483.1k0%no data
0.25%
Sean Ainsworth
175,314US$354.1k271%no data
0.25%
Renaissance Technologies LLC
173,809US$351.1k13.4%no data
0.21%
State Street Global Advisors, Inc.
145,873US$294.7k107%no data
0.2%
James S. Manuso
141,116US$285.1k0%no data
0.2%
Susan Benton
140,023US$282.9k0%no data
0.19%
Creative Planning, LLC
128,366US$259.3k0%no data
0.17%
Bernhard Hoffmann
117,642US$237.6k0%no data
0.16%
Citadel Advisors LLC
113,416US$229.1k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/12/28 11:22
End of Day Share Price 2025/12/26 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Opus Genetics, Inc. is covered by 9 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
James MolloyAlliance Global Partners
Madison Wynne El-SaadiB. Riley Securities, Inc.
Kumaraguru RajaBrookline Capital Markets